Compare Noble Corporation plc (NE) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Noble Corporation plc vs Repligen Corporation Common Stock — how do they compare? Noble Corporation plc trades at $42.9 (market cap $6.93B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Repligen Corporation Common Stock is the larger of the two by market cap, and Noble Corporation plc pays a 4.61% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Noble Corporation plc for 27 Days and Repligen Corporation Common Stock for 0 Days on average.
| NE | RGEN | |
|---|---|---|
Market Cap | $6.93B | $11.14B |
Volume | 747,410 | 1,259,263 |
Sector | Energy | Health |
52-Week High | $54.37 | $194.57 |
52-Week Low | $27.45 | $102.87 |
Typical Hold Time | 27 Days | 0 Days |
Enterprise Value | $8.36B | $11.02B |
Dividend Yield | 4.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Noble Corporation (NE) trades at $43.42, up 1.12% today, with mixed technical signals showing a bullish overall trend but bearish moving averages. The company reported declining revenue from $3.29B in 2025 to $3.1B in 2026, with net income falling to $150M. Recent positive developments include securing a long-term drilling contract in Ghana, though investor sentiment is tempered by an ongoing legal investigation and inconsistent quarterly earnings performance.
Outlook remains cautious with analyst consensus price target of $52 offering 20% upside potential, but risks include earnings volatility, legal scrutiny, and competitive pressures in offshore drilling. The stock presents moderate opportunity for value investors given reasonable valuation multiples, but requires careful monitoring of contract execution and resolution of legal matters.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
